| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues: |
| Three Suppliers | 26.8 | | | | 16.8 | | | |
| Four Product Concentration Risk | 16.1 | | | | 7.5 | | | |
| Single Customer | 9.0 | | | | | | | |
| Two Product Concentration Risk | | 9.4 | 7.6 | 7.8 | | 7.1 | 6.5 | 6.5 |
| Other | | 16.7 | 12.7 | 15.1 | | 15.0 | 13.6 | 12.2 |
| Total revenues | 33.5 | 26.1 | 20.3 | 22.8 | 23.3 | 22.1 | 20.2 | 18.7 |
| Revenue growth [+] | 43.5% | 18.0% | 0.7% | 22.0% | 28.6% | 43.2% | 38.3% | 29.9% |
| Three Suppliers | 59.5% | | | | | | | |
| Four Product Concentration Risk | 115.3% | | | | | | | |
| Two Product Concentration Risk | | 32.8% | 16.1% | 18.5% | | | | |
| Cost of goods sold | 10.0 | 8.3 | 6.2 | 6.7 | 6.5 | 6.0 | 5.1 | 4.9 |
| Gross profit | 23.5 | 17.8 | 14.2 | 16.1 | 16.8 | 16.2 | 15.1 | 13.8 |
| Gross margin | 70.1% | 68.3% | 69.7% | 70.6% | 72.0% | 73.0% | 74.8% | 73.6% |
| Selling, general and administrative [+] | 20.0 | 15.9 | 15.2 | 15.4 | 14.2 | 13.4 | 12.7 | 11.4 |
| General and administrative | | | 15.2 | | | | 12.7 | |
| Research and development | 1.2 | 0.7 | 0.7 | 0.8 | 0.9 | 0.7 | 3.9 | 6.1 |
| Equity in earnings | | | -2.1 | -3.5 | -2.6 | -2.9 | -2.4 | -0.7 |
| Other operating expenses | | | -0.7 | | | | | |
| EBITDA [+] | 5.6 | 3.7 | -2.4 | -3.0 | -0.5 | -0.4 | -3.4 | -4.1 |
| EBITDA growth | -1151.3% | -1113.4% | -29.4% | -28.0% | -114.3% | -110.8% | -130.4% | -508.3% |
| EBITDA margin | 16.7% | 14.2% | -11.9% | -12.9% | -2.3% | -1.7% | -17.0% | -21.9% |
| Depreciation | 0.4 | 0.3 | 0.4 | 0.2 | 0.0 | 0.0 | 0.4 | 0.3 |
| EBITA | 5.2 | 3.4 | -2.8 | -3.2 | -0.6 | -0.4 | -3.8 | -4.4 |
| EBITA margin | 15.5% | 13.1% | -13.8% | -14.0% | -2.4% | -1.7% | -19.0% | -23.4% |
| Amortization of intangibles | 2.8 | 2.2 | 0.4 | 0.4 | 0.4 | 0.4 | 0.0 | 0.0 |
| EBIT [+] | 2.4 | 1.2 | -3.2 | -3.6 | -1.0 | -0.8 | -3.9 | -4.4 |
| EBIT growth | -346.0% | -254.1% | -17.7% | -18.7% | -129.6% | -126.9% | -136.5% | -917.6% |
| EBIT margin | 7.0% | 4.6% | -15.7% | -15.8% | -4.1% | -3.5% | -19.2% | -23.6% |
| Non-recurring items | | | 0.7 | | | | 0.2 | |
| Interest expense | 5.7 | 4.7 | 1.9 | 1.8 | 1.8 | 1.8 | 1.9 | 1.7 |
| Interest expense | 5.7 | 4.7 | 1.9 | 1.8 | 1.8 | 1.8 | 1.9 | 1.7 |
| Other income (expense), net [+] | -0.9 | -3.4 | 6.8 | -1.0 | -3.4 | 0.1 | -1.2 | -2.2 |
| Gain (loss) on investments | -0.7 | 2.0 | 1.4 | -1.0 | -3.4 | 0.1 | -1.5 | -2.2 |
| Other | -0.2 | 0.0 | | | | | 0.2 | |
| Pre-tax income | -4.2 | -6.9 | 1.1 | -6.4 | -6.2 | -2.4 | -7.3 | -8.3 |
| Income taxes | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Tax rate | 0.4% | 4.2% | 0.0% | | | 0.0% | | 0.0% |
| Net income | -4.2 | -6.6 | 1.1 | -6.5 | -6.2 | -2.4 | -7.4 | -8.3 |
| Net margin | -12.6% | -25.4% | 5.2% | -28.3% | -26.8% | -11.0% | -36.7% | -44.5% |
| |
| Basic EPS [+] | ($0.14) | ($0.22) | $0.04 | ($0.24) | ($0.23) | ($0.09) | ($0.28) | ($0.31) |
| Growth | -39.2% | 144.9% | -113.9% | -23.1% | 107.1% | -1173.7% | -724.8% | -192.2% |
| Diluted EPS [+] | ($0.14) | ($0.22) | $0.04 | ($0.24) | ($0.23) | ($0.09) | ($0.28) | ($0.31) |
| Growth | -39.2% | 144.9% | -113.9% | -23.1% | 107.1% | -1234.0% | -724.8% | -196.3% |
| |
| Shares outstanding (basic) [+] | 30.5 | 30.3 | 27.5 | 27.3 | 27.3 | 27.2 | 26.8 | 27.1 |
| Growth | 11.6% | 11.2% | 2.6% | 0.9% | 2.1% | 4.6% | 3.3% | 4.6% |
| Shares outstanding (diluted) [+] | 30.5 | 30.3 | 27.5 | 27.3 | 27.3 | 27.2 | 26.8 | 27.1 |
| Growth | 11.6% | 11.2% | 2.6% | 0.9% | 2.1% | -0.9% | 3.3% | 0.1% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |